1. ABOUT US

    #

    about us

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  2. RESEARCH REPORTS

    RESEARCH REPORTS

    RESEARCH REPORTS

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  3. METHODOLOGY

    #

    METHODOLOGY

    Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients.

    Read More
  4. Consulting

    #

    Consulting

    Azoth Analytics Consulting assists clients across the globe to enter, progress, and develop in the targeted market through our fact-based business intelligence. We deliver practical and implementable solutions to our domestic and international clients. Our analysts are skilled with techniques of data gathering, market sizing, forecasting, analyzing and providing competitive intelligence and provide progressive research in verticals including healthcare & pharmaceutical...

    Read More
  5. media center

    #

    media center

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
news

     Home >> Research Report >> Healthcare & Pharma >> Global Medical Cannabis Market - Analysis By Product Type (Indica, Sativa), By Application (Chronic Pain, Mental Disorder, Cancer), By Consumption Pattern (Flowers, Concentrates, Edibles), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)
 

Global Medical Cannabis Market - Analysis By Product Type (Indica, Sativa), By Application (Chronic Pain, Mental Disorder, Cancer), By Consumption Pattern (Flowers, Concentrates, Edibles), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)-- By Region (North America, Europe, APAC, ROW), By Country (US, Canada, Germany, Italy, Czech Republic, Croatia, Thailand, Australia, Uruguay, Turkey)

 
Publish Date:March 2019
No. of Pages:290
Format: Pdf (Instant Download)
 
 
Social
Electronic Access - Single User License toll
$2400
 
Electronic Access - Multi User License toll
$3000
 
Hard Copy Mail Delivery toll
$2600
 
 
Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Medical Cannabis Market. The report analyzes the Global Medical Cannabis Market By Product Type (Cannabis Indica, Cannabis Sativa, Others), By Application (Chronic Pain, Mental Disorders, Cancer, Others) and By Consumption Pattern (Flowers, Concentrates, Edibles, Others). The Global Medical Cannabis Market has been analyzed By Region (North America, Europe, APAC, ROW), By Countries (US, Canada, Germany, Italy, Czech Republic, Croatia, Thailand, Australia, Uruguay, Turkey) for the historical period of 2014-2018 and the forecast period of 2019-2024.  

According to Azoth Analytics research report “Global Medical Cannabis Market - Analysis By Product Type (Cannabis Indica, Cannabis Sativa, Others), By Application (Chronic Pain, Mental Disorders, Cancer, Others), By Consumption Pattern (Flowers, Concentrates, Edibles, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (North America, Europe, APAC, ROW), By Country (US, Canada, Germany, Italy, Czech Republic, Croatia, Thailand, Australia, Uruguay, Turkey)”, global  market is projected to display a robust growth represented by a CAGR of  16.82% during 2019 – 2024.

Cannabis Indica has been witnessing growth at a noteworthy rate over the past few years as cannabis is being legalized in most of the nations with multi-application in various industries such as Food and Beverage, Paper, Textile, Healthcare, Skin and Beauty Products among others. Amongst the regions, North America accounts for the largest regional share in the global medical cannabis market in 2019. Key factors driving robust growth rate in North America region include escalating production of cannabis, with government legalizing cannabis in most of the states of US clubbed with presence of major global cannabis leaders in Canada, has been anticipated to infuse positive growth in the region during the forecast period.

The report titled “Global Medical Cannabis Market - Analysis By Product Type (Cannabis Indica, Cannabis Sativa, Others), By Application (Chronic Pain, Mental Disorders, Cancer, Others), By Consumption Pattern (Flowers, Concentrates, Edibles, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (North America, Europe, APAC, ROW), By Country (US, Canada, Germany, Italy, Czech Republic, Croatia, Thailand, Australia, Uruguay, Turkey)” has covered and analyzed the potential of Global Medical Cannabis market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Medical Cannabis market. Additionally, the report also highlights market entry strategies for various companies across the globe. 

Scope of the Report

Global Medical Cannabis Market (Actual Period: 2014-2018, Forecast Period: 2019-2024
• Global Medical Cannabis Market – Size, Growth, Forecast
• By Production Type (Cannabis Indica, Cannabis Sativa, Others)
• By Application (Chronic Pain, Mental Disorders, Cancer, Others)
• By Consumption Patters (Flowers, Concentrates, Edibles, Others)

Regional Markets – North America, Europe, APAC and Rest of the World (Actual Period: 2014-2018, Forecast Period: 2019-2024)
• Regional Medical Cannabis Market – Size, Growth, Forecast
• By Production Type (Cannabis Indica, Cannabis Sativa, Others)
• By Application (Chronic Pain, Mental Disorders, Cancer, Others)
• By Consumption Patters (Flowers, Concentrates, Edibles, Others)

Country Analysis – US, Canada, Germany, Italy, Czech Republic, Croatia, Thailand, Australia, Uruguay, Turkey (Actual Period: 2014-2018, Forecast Period: 2019-2024)
• Medical Cannabis Market – Size and Growth
• By Production Type (Cannabis Indica, Cannabis Sativa, Others)
• By Application (Chronic Pain, Mental Disorders, Cancer, Others)
• By Consumption Patters (Flowers, Concentrates, Edibles, Others)

Other Report Highlights
• Market Dynamics – Drivers and Restraints
• Market Trends
• SWOT Analysis
• Competitive Landscape
• Company Analysis – Scotts Miracle-Gro Co, Canopy Growth Corp(Canada), GW Pharmaceuticals PLC, Aurora Cannabis Inc (Canada), Aphria Inc (Canada), MedReLeaf Corp, Medical Marijuana, INC, Insys Therapeutics Inc, CanniMed Therapeutics Inc, Cara Therapeutics Inc.

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research. 

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Medical Cannabis Market: Product Outlook

5. Global Medical Cannabis Market: An Analysis
5.1 By Value (2014-2018)
5.2 By Value (2019-2024)

6. Global Medical Cannabis Market: Segment Analysis
6.1 By Production Type (2018, 2024)
6.1.1 Global Cannabis Indica Market Size, By Value (2014-2018) (2019-2024)
6.1.2 lobal Cannabis Sativa Market Size, By Value (2014-2018) (2019-2024)
6.1.3 Global Cannabis Market Size - Others, By Value (2014-2018) (2019-2024)
6.2 By Application (2018, 2024)
6.2.1 Global Medical Cannabis Market Size for Chronic Pain, By Value (2014-2018) (2019-2024)
6.2.2 Global Medical Cannabis Market Size for Mental Disorders, By Value (2014-2018) (2019-2024)
6.2.3 Global Medical Cannabis Market Size for Cancers, By Value (2014-2018) (2019-2024)
6.2.4 Global Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)
6.3 By Consumption Pattern (2018, 2024)
6.3.1 Global Medical Cannabis Market Size for Flowers, By Value (2014-2018) (2019-2024)
6.3.2 Global Medical Cannabis Market Size for Concentrates, By Value (2014-2018) (2019-2024)
6.3.3 lobal Medical Cannabis Market Size for Edibles, By Value (2014-2018) (2019-2024)
6.3.4 Global Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)

7. Market Share of Leading Medical Cannabis Companies

8. Global Medical Cannabis Market: Regional Analysis

9. North America Medical Cannabis Market: An Analysis
9.1 By Value (2014-2018)
9.2 By Value (2019-2024)

10. North America Medical Cannabis Market: Segment Analysis
10.1 By Production Type (2018, 2024)
10.1.1 North America Cannabis Indica Market Size, By Value (2014-2018) (2019-2024)
10.1.2 North America Cannabis Sativa Market Size, By Value (2014-2018) (2019-2024)
10.1.3 North America Cannabis Market Size - Others, By Value (2014-2018) (2019-2024)
10.2 By Application (2018, 2024)
10.2.1 North America Medical Cannabis Market Size for Chronic Pain, By Value (2014-2018) (2019-2024)
10.2.2 North America Medical Cannabis Market Size for Mental Disorders, By Value (2014-2018) (2019-2024)
10.2.3 North America Medical Cannabis Market Size for Cancers, By Value (2014-2018) (2019-2024)
10.2.4 North America Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)
10.3 By Consumption Pattern (2018, 2024)
10.3.1 North America Medical Cannabis Market Size for Flowers, By Value (2014-2018) (2019-2024)
10.3.2 North America Medical Cannabis Market Size for Concentrates, By Value (2014-2018) (2019-2024)
10.3.3 North America Medical Cannabis Market Size for Edibles, By Value (2014-2018) (2019-2024)
10.3.4 North America Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)

11. North America Medical Cannabis Market: Country Analysis 

11.1 US Medical Cannabis Market
11.1.1 US Medical Cannabis Market, By Value (2014-2018)
11.1.2 US Medical Cannabis Market, By Value (2019-2024)
11.1.3 By Production Type, (2014-2018) (2019-2024)
11.1.4 By Application, (2014-2018) (2019-2024)
11.1.5 By Consumption Pattern, (2014-2018) (2019-2024)

11.2 Canada Medical Cannabis Market
11.2.1 Canada Medical Cannabis Market, By Value (2014-2018)
11.2.2 Canada Medical Cannabis Market, By Value (2019-2024)
11.2.3 By Production Type, (2014-2018) (2019-2024)
11.2.4 By Application, (2014-2018) (2019-2024)
11.2.5 By Consumption Pattern, (2014-2018) (2019-2024)

11.3 Rest of North America Medical Cannabis Market
11.3.1 Rest of North America Medical Cannabis Market, By Value (2014-2018) (2019-2024)
11.3.2 By Production Type, (2014-2018) (2019-2024)
11.3.3 By Application, (2014-2018) (2019-2024)
11.3.4 By Consumption Pattern, (2014-2018) (2019-2024)

12. Europe Medical Cannabis Market: An Analysis
12.1 By Value (2014-2018)
12.2 By Value (2019-2024)

13. Europe America Medical Cannabis Market: Segment Analysis
13.1 By Production Type (2018, 2024)
13.1.1 Europe Cannabis Indica Market Size, By Value (2014-2018) (2019-2024)
13.1.2 Europe Cannabis Sativa Market Size, By Value (2014-2018) (2019-2024)
13.1.3 Europe Cannabis Market Size - Others, By Value (2014-2018) (2019-2024)
13.2 By Application (2018, 2024)
13.2.1 Europe Medical Cannabis Market Size for Chronic Pain, By Value (2014-2018) (2019-2024)
13.2.2 Europe Medical Cannabis Market Size for Mental Disorders, By Value (2014-2018) (2019-2024)
13.2.3 Europe Medical Cannabis Market Size for Cancers, By Value (2014-2018) (2019-2024)
13.2.4 Europe Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)
13.3 By Consumption Pattern (2018, 2024)
13.3.1 Europe Medical Cannabis Market Size for Flowers, By Value (2014-2018) (2019-2024)
13.3.2 Europe Medical Cannabis Market Size for Concentrates, By Value (2014-2018) (2019-2024)
13.3.3 Europe Medical Cannabis Market Size for Edibles, By Value (2014-2018) (2019-2024)
13.3.4 Europe Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)

14 Europe Medical Cannabis Market: Country Analysis 

14.1 Germany Medical Cannabis Market
14.1.1 Germany Medical Cannabis Market, By Value (2014-2018)
14.1.2 Germany Medical Cannabis Market, By Value (2019-2024)
14.1.3 By Production Type, (2014-2018) (2019-2024)
14.1.4 By Application, (2014-2018) (2019-2024)
14.1.5 By Consumption Pattern, (2014-2018) (2019-2024)

14.2 Italy Medical Cannabis Market
14.2.1 Italy Medical Cannabis Market, By Value (2014-2018)
14.2.2 Italy Medical Cannabis Market, By Value (2019-2024)
14.2.3 By Production Type, (2014-2018) (2019-2024)
14.2.4 By Application, (2014-2018) (2019-2024)
14.2.5 By Consumption Pattern, (2014-2018) (2019-2024)

14.3 Czech Republic Medical Cannabis Market
14.3.1 Czech Republic Medical Cannabis Market, By Value (2014-2018)
14.3.2 Czech Republic Medical Cannabis Market, By Value (2019-2024)
14.3.3 By Production Type, (2014-2018) (2019-2024)
14.3.4 By Application, (2014-2018) (2019-2024)
14.3.5 By Consumption Pattern, (2014-2018) (2019-2024)

14.4 Croatia Medical Cannabis Market
14.4.1 Croatia Medical Cannabis Market, By Value (2014-2018)
14.4.2 Croatia Medical Cannabis Market, By Value (2019-2024)
14.4.3 By Production Type, (2014-2018) (2019-2024)
14.4.4 By Application, (2014-2018) (2019-2024)
14.4.5 By Consumption Pattern, (2014-2018) (2019-2024)

14.3 Rest of Europe Medical Cannabis Market
14.3.1 Rest of Europe Medical Cannabis Market, By Value (2014-2018) (2019-2024)
14.3.2 By Production Type, (2014-2018) (2019-2024)
14.3.3 By Application, (2014-2018) (2019-2024)
14.3.4 By Consumption Pattern, (2014-2018) (2019-2024)

15. Asia Pacific Medical Cannabis Market: An Analysis
15.1 By Value (2014-2018)
15.2 By Value (2019-2024)

16. Asia Pacific Medical Cannabis Market: Segment Analysis
16.1 By Production Type (2018, 2024)
16.1.1 Asia Pacific Cannabis Indica Market Size, By Value (2014-2018) (2019-2024)
16.1.2 Asia Pacific Cannabis Sativa Market Size, By Value (2014-2018) (2019-2024)
16.1.3 Asia Pacific Cannabis Market Size - Others, By Value (2014-2018) (2019-2024)
16.2 By Application (2018, 2024)
16.2.1 Asia Pacific Medical Cannabis Market Size for Chronic Pain, By Value (2014-2018) (2019-2024)
16.2.2 Asia Pacific Medical Cannabis Market Size for Mental Disorders, By Value (2014-2018) (2019-2024)
16.2.3 Asia Pacific Medical Cannabis Market Size for Cancers, By Value (2014-2018) (2019-2024)
16.2.4 Asia Pacific Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)
16.3 By Consumption Pattern (2018, 2024)
16.3.1 Asia Pacific Medical Cannabis Market Size for Flowers, By Value (2014-2018) (2019-2024)
16.3.2 Asia Pacific Medical Cannabis Market Size for Concentrates, By Value (2014-2018) (2019-2024)
16.3.3 Asia Pacific Medical Cannabis Market Size for Edibles, By Value (2014-2018) (2019-2024)
16.3.4 Asia Pacific Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)

17. Asia Pacific Medical Cannabis Market: Country Analysis 

17.1 Thailand Medical Cannabis Market
17.1.1 Thailand Medical Cannabis Market, By Value (2014-2018)
17.1.2 Thailand Medical Cannabis Market, By Value (2019-2024)
17.1.3 By Production Type, (2014-2018) (2019-2024)
17.1.4 By Application, (2014-2018) (2019-2024)
17.1.5 By Consumption Pattern, (2014-2018) (2019-2024)

17.2 Australia Medical Cannabis Market
17.2.1 Australia Medical Cannabis Market, By Value (2014-2018)
17.2.2 Australia Medical Cannabis Market, By Value (2019-2024)
17.2.3 By Production Type, (2014-2018) (2019-2024)
17.2.4 By Application, (2014-2018) (2019-2024)
17.2.5 By Consumption Pattern, (2014-2018) (2019-2024)

17.3 Rest of Asia Pacific Medical Cannabis Market
17.3.1 Rest of Asia Pacific Medical Cannabis Market, By Value (2014-2018) (2019-2024)
17.3.2 By Production Type, (2014-2018) (2019-2024)
17.3.3 By Application, (2014-2018) (2019-2024)
17.3.4 By Consumption Pattern, (2014-2018) (2019-2024)

18 Rest of the World Medical Cannabis Market : An Analysis
18.1 By Value (2014-2018)
18.2 By Value (2019-2024)

19. Rest of the World Medical Cannabis Market : Segment Analysis
19.1 By Production Type (2018, 2024)
19.1.1 Rest of the World Cannabis Indica Market Size, By Value (2014-2018) (2019-2024)
19.1.2 Rest of the World Cannabis Sativa Market Size, By Value (2014-2018) (2019-2024)
19.1.3 Rest of the World Cannabis Market Size - Others, By Value (2014-2018) (2019-2024)
19.2 By Application (2018, 2024)
19.2.1 Rest of the World Medical Cannabis Market Size for Chronic Pain, By Value (2014-2018) (2019-2024)
19.2.2 Rest of the World Medical Cannabis Market Size for Mental Disorders, By Value (2014-2018) (2019-2024)
19.2.3 Rest of the World Medical Cannabis Market Size for Cancers, By Value (2014-2018) (2019-2024)
19.2.4 Rest of the World Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)
19.3 By Consumption Pattern (2018, 2024)
19.3.1 Rest of the World Medical Cannabis Market Size for Flowers, By Value (2014-2018) (2019-2024)
19.3.2 Rest of the World Medical Cannabis Market Size for Concentrates, By Value (2014-2018) (2019-2024)
19.3.3 Rest of the World Medical Cannabis Market Size for Edibles, By Value (2014-2018) (2019-2024)
19.3.4 Rest of the World Medical Cannabis Market Size for Others, By Value (2014-2018) (2019-2024)

20. Rest of the World Medical Cannabis Market : Country Analysis 

20.1 Uruguay Medical Cannabis Market
20.1.1 Uruguay Medical Cannabis Market, By Value (2014-2018)
20.1.2 Uruguay Medical Cannabis Market, By Value (2019-2024)
20.1.3 By Production Type, (2014-2018) (2019-2024)
20.1.4 By Application, (2014-2018) (2019-2024)
20.1.5 By Consumption Pattern, (2014-2018) (2019-2024)

20.2 Turkey Medical Cannabis Market
20.2.1 Turkey Medical Cannabis Market, By Value (2014-2018)
20.2.2 Turkey Medical Cannabis Market, By Value (2019-2024)
20.2.3 By Production Type, (2014-2018) (2019-2024)
20.2.4 By Application, (2014-2018) (2019-2024)
20.2.5 By Consumption Pattern, (2014-2018) (2019-2024)

20.3 Rest of the World - Others Pacific Medical Cannabis Market
20.3.1 Rest of the World - Others Medical Cannabis Market, By Value (2014-2018) (2019-2024)
20.3.2 By Production Type, (2014-2018) (2019-2024)
20.3.3 By Application, (2014-2018) (2019-2024)
20.3.4 By Consumption Pattern, (2014-2018) (2019-2024)

21. Global Medical Cannabis Market Drivers

22. Global Medical Cannabis Market Restraints

23. Global Medical Cannabis Market Trends

24. SWOT Analysis

25. Company Profiles
25.1 Scotts Miracle-Gro Co
25.2 Canopy Growth Corp(Canada)
25.3 GW Pharmaceuticals PLC
25.4 Aurora Cannabis Inc (Canada)
25.5 Aphria Inc (Canada)
25.6 MedReLeaf Corp
25.7 Medical Marijuana, INC
25.8 Insys Therapeutics Inc
25.9 CanniMed Therapeutics Inc
25.10 Cara Therapeutics Inc.
List of Figures 

Figure 1: Global Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 2: Global Cases of Depressive Disorders, By Region, 2019 (In %)
Figure 3: Global Cases of Anxiety Disorders, By Region, 2019 (In %)
Figure 4: Global Health Expenditure Per Capita, 2012-2016, (USD Trillion)
Figure 5: Global Health Expenditure Per Capita, By Select Countries, 2017, (USD)
Figure 6: Global Prevalence of Different Types of Cancer, 2014-2018 (In Thousand)
Figure 7: Global Number of Medical Doctors Per 10000 Population, By Countries, 2016
Figure 8: Global Prevalence of Prostate Cancer, 2013-2017, (In Thousands)
Figure 9: Global Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 10: Global Medical Cannabis Market  Size, By Product Type, 2018 (%)
Figure 11: Global Medical Cannabis Market  Size, By Product Type, 2024F(%)
Figure 12: Global Medical Cannabis – Cannabis  Indica Market Size, 2014-2018 (USD Million)
Figure 13: Global Medical Cannabis – Cannabis  Indica Market Size, 2019-2024 (USD Million)
Figure 14: Global Medical Cannabis - Cannabis Sativa Market Size, By Value, 2014-2018 (USD Million)
Figure 15: Global Medical Cannabis - Cannabis Sativa Market Size, By Value, 2019-2024 (USD Million)
Figure 16: Global Medical Cannabis - Others Market Size, By Value, 2014-2018 (USD Million)
Figure 17: Global Medical Cannabis - Others Market Size, By Value, 2019-2024 (USD Million)
Figure 18: Global Medical Cannabis Market  Size, By Application, 2018 (%)
Figure 19: Global Medical Cannabis Market  Size, By Application, 2024F(%)
Figure 20: Global Medical Cannabis Market Size - Chronic Pain, 2014-2018 (USD Million)
Figure 21: Global Medical Cannabis Market Size - Chronic Pain, 2019-2024 (USD Million)
Figure 22: Global Medical Cannabis Market Size – Mental Disorders, 2014-2018 (USD Million)
Figure 23: Global Medical Cannabis Market Size – Mental Disorders, 2019-2024 (USD Million)
Figure 24: Global Medical Cannabis Market Size - Cancer, By Value, 2014-2018 (USD Million)
Figure 25: Global Medical Cannabis Market Size - Cancer, By Value, 2019-2024 (USD Million)
Figure 26: Global Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 27: Global Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 28: Global Medical Cannabis Market  Size, By Consumption Pattern, 2018 (%)
Figure 29: Global Medical Cannabis Market  Size, By Consumption Pattern, 2024F(%)
Figure 30: Global Medical Cannabis Market Size - Flowers, 2014-2018 (USD Million)
Figure 31: Global Medical Cannabis Market Size - Flowers, 2019-2024 (USD Million)
Figure 32: Global Medical Cannabis Market Size - Concentrates, By Value, 2014-2018 (USD Million)
Figure 33: Global Medical Cannabis Market Size - Concentrates, By Value, 2019-2024 (USD Million)
Figure 34: Global Medical Cannabis Market Size – Edibles, 2014-2018 (USD Million)
Figure 35: Global Medical Cannabis Market Size – Edibles, 2019-2024 (USD Million)
Figure 36: Global Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 37: Global Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 38: Market Share of leading Medical Cannabis manufacturers, 2019 (In %)
Figure 39: Global Medical Cannabis Market, Regional Share, 2018 (%)
Figure 40: Global Medical Cannabis Market, Regional Share, 2024F(%)
Figure 41: North America Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 42: North America Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In Thousands)
Figure 43: North America Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 44: North America Population aged 65 and above, 2013-2017 (% of Total)
Figure 45: North America Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 46: Major Players in North America Medical Cannabis Market 
Figure 47: North America Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 48: North America Medical Cannabis Market  Size, By Product Type, 2018 (%)
Figure 49: North America Medical Cannabis Market  Size, By Product Type, 2024F(%)
Figure 50: North America Medical Cannabis – Cannabis Indica Market Size, 2014-2018 (USD Million)
Figure 51: North America Medical Cannabis – Cannabis Indica Market Size, 2019-2024 (USD Million)
Figure 52: North America Medical Cannabis - Cannabis Sativa Market Size, By Value, 2014-2018 (USD Million)
Figure 53: North America Medical Cannabis - Cannabis Sativa Market Size, By Value, 2019-2024 (USD Million)
Figure 54: North America Medical Cannabis - Others Market Size, By Value, 2014-2018 (USD Million)
Figure 55: North America Medical Cannabis - Others Market Size, By Value, 2019-2024 (USD Million)
Figure 56: North America Medical Cannabis Market  Size, By Application, 2018 (%)
Figure 57: North America Medical Cannabis Market  Size, By Application, 2024F(%)
Figure 58: North America Medical Cannabis Market Size - Chronic Pain, 2014-2018 (USD Million)
Figure 59: North America Medical Cannabis Market Size - Chronic Pain, 2019-2024 (USD Million)
Figure 60: North America Medical Cannabis Market Size – Mental Disorders, 2014-2018 (USD Million)
Figure 61: North America Medical Cannabis Market Size – Mental Disorders, 2019-2024 (USD Million)
Figure 62: North America Medical Cannabis Market Size - Cancer, By Value, 2014-2018 (USD Million)
Figure 63: North America Medical Cannabis Market Size - Cancer, By Value, 2019-2024 (USD Million)
Figure 64: North America Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 65: North America Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 66: North America Medical Cannabis Market  Size, By Consumption Pattern, 2018 (%)
Figure 67: North America Medical Cannabis Market  Size, By Consumption Pattern, 2024F(%)
Figure 68: North America Medical Cannabis Market Size - Flowers, 2014-2018 (USD Million)
Figure 69: North America Medical Cannabis Market Size - Flowers, 2019-2024 (USD Million)
Figure 70: North America Medical Cannabis Market Size - Concentrates, By Value, 2014-2018 (USD Million)
Figure 71: North America Medical Cannabis Market Size - Concentrates, By Value, 2019-2024 (USD Million)
Figure 72: North America Medical Cannabis Market Size – Edibles, 2014-2018 (USD Million)
Figure 73: North America Medical Cannabis Market Size – Edibles, 2019-2024 (USD Million)
Figure 74: North America Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 75: North America Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 76: US Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 77: US Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 78: US Medical Doctors Per 10000 Population, 2013-2016
Figure 79: US Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 80: US Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 81: US New Cases of Cancer, By Type,  2018 (In %)
Figure 82: US Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 83: US Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 84: US Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 85: US Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 86: Canada Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 87: Canada Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 88: Canada Medical Doctors Per 10000  Population, 2013-2017
Figure 89: Canada Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 90: Canada Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 91: Canada Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 92: Canada Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 93: Canada Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 94: Canada Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 95: Rest of North America Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 96: Rest of North America Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 97: Rest of North America Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 98: Rest of North America Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 99: Rest of North America Medical Cannabis Market: By Consumption Pattern, 2014-2024 (USD Million)
Figure 100: Europe Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 101: Europe Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In Thousands)
Figure 102: Europe Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 103: Europe Population aged 65 and above, 2013-2017 (% of Total)
Figure 104: Europe Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 105: Major Players in Europe Medical Cannabis Market 
Figure 106: Europe Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 107: Europe Medical Cannabis Market Size, By Product Type, 2018 (%)
Figure 108: Europe Medical Cannabis Market Size, By Product Type, 2024F(%)
Figure 109: Europe Medical Cannabis - Cannabis Indica Market Size, 2014-2018 (USD Million)
Figure 110: Europe Medical Cannabis - Cannabis Indica Market Size, 2019-2024 (USD Million)
Figure 111: Europe Medical Cannabis - Cannabis Sativa Market Size, By Value, 2014-2018 (USD Million)
Figure 112: Europe Medical Cannabis - Cannabis Sativa Market Size, By Value, 2019-2024 (USD Million)
Figure 113: Europe Medical Cannabis - Others Market Size, By Value, 2014-2018 (USD Million)
Figure 114: Europe Medical Cannabis - Others Market Size, By Value, 2019-2024 (USD Million)
Figure 115: Europe Medical Cannabis Market  Size, By Application, 2018 (%)
Figure 116: Europe Medical Cannabis Market  Size, By Application, 2024F(%)
Figure 117: Europe Medical Cannabis Market Size - Chronic Pain, 2014-2018 (USD Million)
Figure 118: Europe Medical Cannabis Market Size - Chronic Pain, 2019-2024 (USD Million)
Figure 119: Europe Medical Cannabis Market Size – Mental Disorders, 2014-2018 (USD Million)
Figure 120: Europe Medical Cannabis Market Size – Mental Disorders, 2019-2024 (USD Million)
Figure 121: Europe Medical Cannabis Market Size - Cancer, By Value, 2014-2018 (USD Million)
Figure 122: Europe Medical Cannabis Market Size - Cancer, By Value, 2019-2024 (USD Million)
Figure 123: Europe Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 124: Europe Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 125: Europe Medical Cannabis Market Size, By Consumption Pattern, 2019 (%)
Figure 126: Europe Medical Cannabis Market Size, By Consumption Pattern, 2024F(%)
Figure 127: Europe Medical Cannabis Market Size - Flowers, 2014-2018 (USD Million)
Figure 128: Europe Medical Cannabis Market Size - Flowers, 2019-2024 (USD Million)
Figure 129: Europe Medical Cannabis Market Size - Concentrates, By Value, 2014-2018 (USD Million)
Figure 130: Europe Medical Cannabis Market Size - Concentrates, By Value, 2019-2024 (USD Million)
Figure 131: Europe Medical Cannabis Market Size – Edibles, 2014-2018 (USD Million)
Figure 132: Europe Medical Cannabis Market Size – Edibles, 2019-2024 (USD Million)
Figure 133: Europe Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 134: Europe Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 135: Germany Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 136: Germany Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 137: Germany Medical Doctors Per 10000 Population, 2013-2016
Figure 138: Germany Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 139: Germany Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 140: Germany Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 141: Germany Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 142: Germany Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 143: Germany Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 144: Italy Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 145: Italy Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 146: Italy Medical Doctors Per 10000  Population, 2013-2017
Figure 147: Italy Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 148: Italy Population Aged 65 and Older,  2013-2017 (In Millions)
Figure 149: Italy Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 150: Italy Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 151: Italy Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 152: Italy Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 153: Czech Republic Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 154: Czech Republic Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 155: Czech Republic Medical Doctors Per 10000 Population, 2013, 2016
Figure 156: Czech Republic Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 157: Czech Republic Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 158: Czech Republic Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 159: Czech Republic Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 160: Czech Republic Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 161: Czech Republic Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 162: Croatia Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 163: Croatia Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 164: Croatia Medical Doctors Per 10000 Population, 2013-2016
Figure 165: Croatia Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 166: Croatia Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 167: Croatia Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 168: Croatia Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 169: Croatia Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 170: Croatia Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 171: Rest of Europe Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 172: Rest of Europe Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 173: Rest of Europe Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 174: Rest of Europe Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 175: Rest of Europe Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 176: Asia Pacific Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 177: Asia Pacific Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In Thousands)
Figure 178: Asia Pacific Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 179: Asia Pacific Population aged 65 and above, 2013-2017 (% of Total)
Figure 180: Asia Pacific Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 181: Major Players in Asia Pacific Medical Cannabis Market 
Figure 182: Asia Pacific Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 183: Asia Pacific Medical Cannabis Market Size, By Product Type, 2018 (%)
Figure 184: Asia Pacific Medical Cannabis Market Size, By Product Type, 2024F(%)
Figure 185: Asia Pacific Medical Cannabis - Cannabis Indica Market Size, By Value, 2014-2018 (USD Million)
Figure 186: Asia Pacific Medical Cannabis - Cannabis Indica Market Size, By Value, 2019-2024 (USD Million)
Figure 187: Asia Pacific Medical Cannabis Market Size – Cannabis Sativa, By Value, 2014-2018 (USD Million)
Figure 188: Asia Pacific Medical Cannabis Market Size – Cannabis Sativa, By Value, 2019-2024 (USD Million)
Figure 189: Asia Pacific Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 190: Asia Pacific Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 191: Asia Pacific Medical Cannabis Market Size, By Application, 2019 (%)
Figure 192: Asia Pacific Medical Cannabis Market Size, By Application, 2024F(%)
Figure 193: Asia Pacific Medical Cannabis Market Size - Chronic Pain, 2014-2018 (USD Million)
Figure 194: Asia Pacific Medical Cannabis Market Size - Chronic Pain, 2019-2024 (USD Million)
Figure 195: Asia Pacific Medical Cannabis Market Size – Mental Disorders, 2014-2018 (USD Million)
Figure 196: Asia Pacific Medical Cannabis Market Size – Mental Disorders, 2019-2024 (USD Million)
Figure 197: Asia Pacific Medical Cannabis Market Size - Cancer, By Value, 2014-2018 (USD Million)
Figure 198: Asia Pacific Medical Cannabis Market Size - Cancer, By Value, 2019-2024 (USD Million)
Figure 199: Asia Pacific Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 200: Asia Pacific Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 201: Asia Pacific Medical Cannabis Market Size, By Consumption Pattern, 2019 (%)
Figure 202: Asia Pacific Medical Cannabis Market Size, By Consumption Pattern, 2024F(%)
Figure 203: Asia Pacific Medical Cannabis Market Size - Flowers, 2014-2018 (USD Million)
Figure 204: Asia Pacific Medical Cannabis Market Size - Flowers, 2019-2024 (USD Million)
Figure 205: Asia Pacific Medical Cannabis Market Size - Concentrates, By Value, 2014-2018 (USD Million)
Figure 206: Asia Pacific Medical Cannabis Market Size - Concentrates, By Value, 2019-2024 (USD Million)
Figure 207: Asia Pacific Medical Cannabis Market Size – Edibles, 2014-2018 (USD Million)
Figure 208: Asia Pacific Medical Cannabis Market Size – Edibles, 2019-2024 (USD Million)
Figure 209: Asia Pacific Medical Cannabis Market Size – Others, By Value, 2014-2018 (USD Million)
Figure 210: Asia Pacific Medical Cannabis Market Size – Others, By Value, 2019-2024 (USD Million
Figure 211: Thailand Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 212: Thailand Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 213: Thailand Medical Doctors Per 10000 Population, 2015-2017
Figure 214: Thailand Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 215: Thailand Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 216: Thailand Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 217: Thailand Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 218: Thailand Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 219: Thailand Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 220: Australia Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 221: Australia Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 222: Australia Medical Doctors Per 10000 Population, 2013-2016
Figure 223: Australia Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 224: Australia Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 225: Australia Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 226: Australia Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 227: Australia Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 228: Australia Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 229: Rest of APAC Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 230: Rest of APAC Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 231: Rest of APAC Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 232: Rest of APAC Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 233: Rest of APAC Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 234: Rest of the World Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 235: Rest of the World Prevalence of Different Types of Neurological Disorders, 2016, 2017, (In 
Figure 236: Rest of the World Prevalence of Depressive Disorders, 2013-2017, (In Thousands)
Figure 237: Rest of the World Population aged 65 and above, 2013-2017 (% of Total)
Figure 238: Rest of the World Healthcare Expenditure, 2012-2015 (% of GDP)
Figure 239: Rest of the World Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 240: Rest of the World Medical Cannabis Market Size, By Product Type, 2019 (%)
Figure 241: Rest of the World Medical Cannabis Market Size, By Product Type, 2024F(%)
Figure 242: Rest of the World Medical Cannabis Market Size - Cannabis Indica, By Value, 2014-2018 (USD Million)
Figure 243: Rest of the World Medical Cannabis Market Size - Cannabis Indica, By Value, 2019-2024 (USD Million
Figure 244: Rest of the World Medical Cannabis Market Size - Cannabis Sativa, By Value, 2014-2018 (USD Million)
Figure 245: Rest of the World Medical Cannabis Market Size - Cannabis Sativa, By Value, 2019-2024 (USD Million)
Figure 246: Rest of the World Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million
Figure 247: Rest of the World Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 248: Rest of the World Medical Cannabis Market Size, By Application, 2019 (%)
Figure 249: Rest of the World Medical Cannabis Market Size, By Application, 2024F(%)
Figure 250: Rest of the World Medical Cannabis Market Size - Chronic Pain, 2014-2018 (USD Million)
Figure 251: Rest of the World Medical Cannabis Market Size - Chronic Pain, 2019-2024 (USD Million)
Figure 252: Rest of the World Medical Cannabis Market Size – Mental Disorders, 2014-2018 (USD Million)
Figure 253: Rest of the World Medical Cannabis Market Size – Mental Disorders, 2019-2024 (USD Million)
Figure 254: Rest of the World Medical Cannabis Market Size - Cancer, By Value, 2014-2018 (USD Million)
Figure 255: Rest of the World Medical Cannabis Market Size - Cancer, By Value, 2019-2024 (USD Million)
Figure 256: Rest of the World Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 257: Rest of the World Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 258: Rest of the World Medical Cannabis Market Size, By Consumption Pattern, 2019 (%)
Figure 259: Rest of the World Medical Cannabis Market ize, By Consumption Pattern, 2024F(%)
Figure 260: Rest of the World Medical Cannabis Market Size - Flowers, 2014-2018 (USD Million)
Figure 261: Rest of the World Medical Cannabis Market Size - Flowers, 2019-2024 (USD Million)
Figure 262: Rest of the World Medical Cannabis Market Size - Concentrates, By Value, 2014-2018 (USD Million)
Figure 263: Rest of the World Medical Cannabis Market Size - Concentrates, By Value, 2019-2024 (USD Million)
Figure 264: Rest of the World Medical Cannabis Market Size – Edibles, 2014-2018 (USD Million)
Figure 265: Rest of the World Medical Cannabis Market Size – Edibles, 2019-2024 (USD Million)
Figure 266: Rest of the World Medical Cannabis Market Size - Others, By Value, 2014-2018 (USD Million)
Figure 267: Rest of the World Medical Cannabis Market Size - Others, By Value, 2019-2024 (USD Million)
Figure 268: Uruguay Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 269: Uruguay Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 270: Uruguay Medical Doctors Per 10000 Population, 2016, 2017
Figure 271: Uruguay Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 272: Uruguay Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 273: Uruguay Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 274: Uruguay Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 275: Uruguay Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 276: Uruguay Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 277: Turkey Medical Cannabis Market Size, By Value, 2014-2018 (In USD Million)
Figure 278: Turkey Prevalence of Different Types of Neurological Disorders, 2016, 2017 (In Thousands)
Figure 279: Turkey Medical Doctors Per 10000   Population, 2013, 2014
Figure 280: Turkey Current Health Expenditure, By financing Schemes, 2012 - 2016 (In Millions)
Figure 281: Turkey Population Aged 65 and Older, 2013-2017 (In Millions)
Figure 282: Turkey Medical Cannabis Market Size, By Value, 2019-2024 (In USD Million)
Figure 283: Turkey Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 284: Turkey Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 285: Turkey Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD Million)
Figure 286: Rest of the World Medical Cannabis Market Size, By Value, 2014-2018 (USD Million)
Figure 287: Rest of the World Medical Cannabis Market Size, By Value, 2019-2024 (USD Million)
Figure 288: Rest of the World Medical Cannabis Market: By Product Type, By Value, 2014-2024 (USD Million)
Figure 289: Rest of the World Medical Cannabis Market: By Application, By Value, 2014-2024 (USD Million)
Figure 290: Rest of the World Medical Cannabis Market: By Consumption Pattern, By Value, 2014-2024 (USD 
Figure 291: Scotts Miracle-Gro Co’s Revenue, 2013-2017 (Million USD)
Figure 292: Scotts Miracle-Gro Co’s Sales By Business Segment, 2016 (In %)
Figure 293: Scotts Miracle-Gro Co’s Revenue By Business Segment, 2017 (In %)
Figure 294: Canopy Growth Corp’s Revenue, 2015-2018 (USD Million)
Figure 295: GW Pharmaceuticals PLC’s Revenue, 2013-2017 (In USD Million)
Figure 296: GW Pharmaceuticals PLC’s Revenue, By Business Segment, 2016 (In %)
Figure 297: GW Pharmaceuticals PLC’s Revenue, By Business Segment, 2017 (In %)
Figure 298: Aurora Cannabis Inc’s Revenue, 2016-2018 (In USD Million)
Figure 299: Aurora Cannabis Inc’s Revenue, By Business Area, 2018
Figure 300: Aurora Cannabis Inc’s Revenue, By Region, 2018
Figure 301: Aphria Inc’s Revenue, 2015-2018 (In USD Million)
Figure 302: Aphria Inc’s Gross Profit,2017, 2018 (In USD Million)
Figure 303: Aphria Inc’s Net Income, 2017, 2018 (In USD Million)
Figure 304: Medical Marijuana Inc’s Total Income, 2016, 2017 (In USD Million)
Figure 305: Medical Marijuana Inc’s Gross Profit,2016, 2017 (In USD Million)
Figure 306: Medical Marijuana Inc’s Net Income, 2016, 2017 (In USD Million)
Figure 307: Insys Therapeutics Inc’s Revenue, 2013-2017 (USD Million)
Figure 308: Insys Therapeutics Inc’s Gross Profit, 2013-2017 (USD Million)
Figure 309: Insys Therapeutics Inc’s Net Revenue By Business Area, 2017 (In %)
Figure 310: Cara Therapeutics Inc’s Total Revenue, 2013-2017 (In Thousand USD)
Figure 311: Cara Therapeutics Inc’s Operating Loss, 2013-2017 (In Thousand USD)
Figure 312: Cara Therapeutics Inc’s Net Loss, 2013-2017 (In Thousand USD)

One can also purchase any particular sections from this report. Please send us an email to info@azothanalytics.com with your order details.
 
 
 
 
 Latest Market Research Reports